go to moneycontrol.com
Quote 
NAV 
News 
Messages  
Opinions 
Notices 
[+] SHOW
GlaxoSmithKline Pharmaceuticals Homepage >> Moneycontrol.com >> Stocks >> GlaxoSmithKline >> Pharmaceuticals >> Price/Quote, Highs, Lows, Volumes, Graphs, Bid, Offers, Historic Prices, Financials, Income, Results, Mutual Funds, Background, Management, News, Views, Actions, Interviews, Messages
GlaxoSmithKline Pharmaceuticals (BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016)
1,095.60 11.45 (1.06%)
BSE : Jul 25, 15:52
1,100.10 9.40 (0.86%)
NSE : Jul 25, 15:50
Open 1,082.00 Vol 1,752
Prev. Close 1,084.15
Intraday 52 Week
Highs 1,110.00 1,277.85
Lows 1,081.00 800.00
Open 1,081.10 Vol 11,097
Prev. Close 1,090.70
Intraday 52 Week
Highs 1,108.75 1,290.00
Lows 1,068.00 704.50
BID OFFER
Price 1,090.00 1,095.60
Quantity 2.00 224.00
BID OFFER
Price 0.00 1,100.10
Quantity 0.00 222.00
Mkt Cap 9,280.06 | * P/E 16.95 | Div 360.00 | * EPS (TTM) 64.65 | B/V: 160.67
Mkt Lot 1.00 | FV 10.00 | * EPS: As per stand alone adjusted profit after extra-ordinary items
Historic Prices & Returns of GlaxoSmithKline Compare Price Performance With Peers
Price 1 week 2 week 1 month 3 month 6 month 9 month 1 year
BSE / NSE
1133.70 1165.85 1100.35 1001.20 869.15 1035.20 1248.95
-3.36% -6.03% -0.43% 9.43% 26.05% 5.83% -12.28%
Gain/Loss
On :
1 Week 1 Month 3 Month 1 Year 2 Year 3 Year
Historic Graph of GlaxoSmithKline
From : To :
This page Auto Refreshes every 5 minutes
Messages Add to:
News on GlaxoSmithKline
23-07 Strides Arcolab, GSK in branded generics biz deal  
23-07 Strides / Aspen JV in-licensing deal with GSK
Views on GlaxoSmithKline

No Views in the last 7 days

Action on GlaxoSmithKline

No articles in the last 7 days

Interviews on GlaxoSmithKline
25-06 See Nifty support at 3600-4200 levels: Sukhani  
on GlaxoSmithKline
Buy, Sell or Hold?- 29 opinions
1 boarder queriesAnswer now
Have a tip or opinion? Post your view

Messages on GlaxoSmithKline
                  
No messages in the last 7 days
View Messages :
7 days to 3 months | 3 to 9 months | > 9 months
To Post a new message Click here
BSE/NSE Notices - GlaxoSmithKline
Financials of GlaxoSmithKline Quarterly Annual
Income Statement (Mar '08) (Dec '07)
Net Sales 421.52 1578.58
Other Income 34.10 241.51
PBDIT 186.28 822.99
Net Profit 121.27 537.66
Profit & Loss | Half Yearly Results | Quarterly Results |
Dividends | Bonus | Rights | Splits | Locations
Balance Sheet
Total Share Capital 84.70
Net Worth 1360.91
Total Debt 5.77
Net Block 87.47
Investments 1333.32
Net Current Assets -59.55
Total Assets 1366.67
Balance Sheet | Finished Goods | Raw Materials
Mutual Funds Holding - GlaxoSmithKline
Scheme Name No. of shr
142,240
142,240
115,333
100,866
94,387
Are MFs buying or dumping GlaxoSmithKline
Are fund managers betting on Pharmaceuticals sector
Groups: Pharmaceuticals
Company Last Price Market Cap
1,413.90 29,284.19
481.25 17,962.07
225.60 17,535.69
679.40 16,992.28
634.75 10,682.68
Compare with its peer group stocks on
Price Market Cap. Net Sales
Net Profit Total Assets
Simple Moving Averages
Days BSE NSE
30 1117.23 1118.06
50 1109.07 1110.25
150 1037.06 1038.34
200 1038.16 1039.75
Has GlaxoSmithKline made any Bar Patterns today?
Has GlaxoSmithKline made any Candlestick Patterns today?
Company Facts - GlaxoSmithKline
Registered Address
Dr. Annie Besant Road

Mumbai
Maharashtra
400030
Tel : 022-24959595 24933871 24933514
Fax : 022-24959494 24935358
Email : askus@gsk.com
Website :
http://www.gsk-india.com
Registrars
Glaxosmithkline Consumer Healthcare Ltd. DLF Plaza Tower


Tel : 26540700-03
Fax : 0124-26540720
Email :
Website :
 Intra Day Block Deals | Research Reports | Company Background | Listing Info
 Search all bulk deals in GlaxoSmithKline Pharmaceuticals
Management - GlaxoSmithKline
D S Parekh Chairman / Chair Person
V Thyagarajan Vice Chairman
H B Joshipura Managing Director
P Bains Director
R R Bajaaj Director
A Banerjee Director
M B Kapadia Director
N Kaviratne Director
V Narayanan Director
P V Nayak Director
M Reilly Director
Ronald C Sequeira Director
Type
S GlaxoSmithKline
SMS to 52622 you
will receive the latest quote on both BSE & NSE.
Announcements
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends
Information
Company History
Background
Board of Directors
Capital Structure
Listing Info
Locations
Bulk Deals
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Half Yearly Results
Nine Monthly Results
Yearly Results
Cash Flow
Annual Report
Directors Report
Chairman's Speech
Auditors Report
Notes to Accounts
Finished Goods
Raw Materials
Peer Comparison
Price
Price Performance
Market Cap
Net Sales
Net Profit
Total Assets
Related links